After yesterday’s publication of the results of the Research Excellent Framework (#REF2014) comes the post-mortem, introspection and then inevitable debate about REF2020. We will have to wait a wee while before we learn more about the impact assessment aspect of #REF2014 and the overall story it tells us about how research in higher education instiutions… Read More In support of the Rome Declaration on responsible research and innovation
It is no surprise that, in death as in life, Nelson Mandela has caused us to gaze upon humanity with warmth and optimism. I am sure I am not alone in having taken a great deal of pleasure from reading the celebrations of his life and reflecting on how different tomorrow would look were it not… Read More A nod to Nelson Mandela on the eve of the G8 Dementia Summit (agenda published)
I spoke at the Clinical Discovery 2012 conference yesterday about the future value and impact of clinical research. This is one of a number of similar events I’ve presented at over the last month or so. On reflection there generally seems a more ‘upbeat’ conversation among conference-goers about clinical research in the UK compared to this time last… Read More GSK’s Witty remarks are easy to swallow from a patient perspective but the rest of the flock must follow
Just in case you had missed it, it’s all about patient experience from now on! And a good thing too. Or, at the very least, it seems the intention is to ask people more questions about their experience. A lot more questions in fact. In the new world, I wonder, will we be met by NHS ‘chuggers’… Read More Are you a patient? Then, I’m holding you for questioning. You have the right to…..
Good Guardian blog yesterday giving a lay summary of the ‘open access’ debate vis a vis papers published in scientific journals. There’s also been a healthy exchange of letters in The Times this week but ironically that’s behind their paywall. However, at least The Times is available in all good newsagents at a reasonable price. Unsurprisingly, I… Read More The public interest argument must extend beyond open access…here’s a sort of lay summary
There was an online discussion hosted by The Guardian this morning about commercially sponsored clinical trials in the NHS. You can get the jist here.
The summer break has clearly done the Secretary of State for Health, Andrew Lansley, a world of good. From beating a lone path as the libertarian Claudius in the face of a centralised health service, he has resurfaced this week as the man for all seasons to launch a competition for the best ideas for… Read More From I Claudius to iLansley…phone apps in the new NHS